Independent Research set a €83.00 ($93.26) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report published on Friday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
Several other analysts have also weighed in on FME. Nord/LB set a €82.00 ($92.13) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Monday, May 18th. UBS Group set a €95.00 ($106.74) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday, June 24th. Credit Suisse Group set a €81.00 ($91.01) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Friday. Goldman Sachs Group set a €84.00 ($94.38) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Thursday. Finally, JPMorgan Chase & Co. set a €94.80 ($106.52) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Thursday. Five equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of Buy and an average price target of €83.07 ($93.34).
Shares of ETR:FME traded up €0.58 ($0.65) during trading on Friday, hitting €74.62 ($83.84). The company had a trading volume of 921,111 shares, compared to its average volume of 704,197. The stock has a market cap of $21.89 billion and a price-to-earnings ratio of 18.36. The company has a debt-to-equity ratio of 109.85, a current ratio of 0.91 and a quick ratio of 0.61. The company has a fifty day simple moving average of €76.49 and a two-hundred day simple moving average of €70.64. Fresenius Medical Care AG & Co. KGaA has a one year low of €53.50 ($60.11) and a one year high of €81.10 ($91.12).
Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Recommended Story: What is the Beige Book?
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.